Analysis of the Global Fibrinogen Market and Product Pipeline
Analysis of the Global Fibrinogen Market and Product Pipeline
Launch of Topical and Ready-to-Use Fibrin Sealants Impetus to Growth
08-Dec-2015
Global
$6,000.00
Special Price $4,500.00 save 25 %
Description
The increased demand for fibrinogen and the development of innovative delivery systems such as sprays and patches are fuelling the growth of the fibrinogen market. This research service provides a detailed assessment of the global fibrinogen market, covering the current market scenario and growth prospects for the period 2015–2020. Both marketed and pipeline products are segmented based on their therapeutic uses, namely, deficiency therapy and operative care. An elaborate discussion on clinical trial timelines and results, along with historical and projected launch timelines, has been provided. The study also discusses key companies such as CSL Behring, LFB, Baxter Healthcare, Takeda, Grifols, and Octapharma.
Table of Contents
Executive Summary—Key Findings
Executive Summary—Key Findings (continued)
Key Trends
Companies to Watch
Methodology and Scope
Market Overview—Introduction
Market Overview—Blood Plasma Production
Market Segmentation
Blood Plasma Market Share
Fibrinogen Production
Revenue Forecast
Revenue Forecast Discussion
Supply Chain and Distribution Network
Supply Chain and Distribution Network (continued)
Competitive Landscape—Marketed and Pipeline Products
Competitive Landscape Overview
Marketed Products—Deficiency and Other Therapies
Pipeline Products—Deficiency and Other Therapies
Marketed Products—Operative Care
Marketed Products—Operative Care (continued)
Pipeline Products—Operative Care
Fibrinogen Market—Major On-going/Recently Completed Clinical Trials
Fibrinogen Market—Major On-going/Recently Completed Clinical Trials (continued)
Fibrinogen Market—Major On-going/Recently Completed Clinical Trials (continued)
Summary of Key Products to Watch
Summary of Key Products to Watch (continued)
Timeline of Key Events—Launch of Products
Product Dashboard—Haemocomplettan/RiaSTAP (CSL Behring)
Product Dashboard—Clottafact (LFB)
Product Dashboard—Octafibrin (Octapharma)
Product Dashboard—Artiss (Baxter Healthcare)
Product Dashboard—Evarrest (Ethicon)
Product Dashboard—Raplixa (The Medicines Company)
Product Dashboard—FS Grifols (Grifols)
Conclusions
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Related Research
Popular Topics
No Index | No |
---|---|
Podcast | No |
Author | Sriram Radhakrishnan |
WIP Number | MB93-01-00-00-00 |
Is Prebook | No |